Biotechnology
Claim pageClaim
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
51-200
employees, estimated range
Backers
1
Sydney Angels
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Overview
Top of page The Company . AUSTRALIAN-US BIOTECH COMPANY NOVAPEP IS DEVELOPING G10 AN AGONIST POLYPEPTIDE THAT MIMICS THE CELL SIGNALING ACTIVITY OF ACTIVATED PROTEIN C (APC).
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
La Jolla
United States
HQ
50-200 est. staff

Sydney Angels